मूलभूत आँकड़े
| CIK | 1463959 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to DS Healthcare Group, Inc.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| July 27, 2018 |
DSKX / DS Healthcare Group, Inc. CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 16, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 10, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio |
|
| July 10, 2018 |
Press Release issued by Medilogistics Corp., issued on July 10, 2018. Press Release EXHIBIT (a)(1)(xi) MEDILOGISTICS CORP. ANNOUNCES EXPIRATION OF SUBSEQUENT OFFERING PERIOD AND FINAL RESULTS OF OFFER MIAMI, Fla., July 10, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont, announced the final results of, and expiration o |
|
| July 10, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 9) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go |
|
| June 25, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 8) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer |
|
| June 25, 2018 |
Press Release issued by Medilogistics Corp., issued on June 25, 2018. Press Release EXHIBIT (a)(1)(x) MEDILOGISTICS CORP. ANNOUNCES EXPIRATION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK AND COMMENCEMENT OF SUBSEQUENT OFFERING PERIOD MIAMI, Fla., June 25, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Mig |
|
| June 21, 2018 |
PROMISSORY NOTE EXHIBIT (d)(1)(vi) PROMISSORY NOTE $10,500 USD June 18, 2018 This Promissory Note (“Note”) is made and entered into by DS Healthcare Group, Inc. |
|
| June 21, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 7) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go |
|
| June 19, 2018 |
DSKX / DS Healthcare Group, Inc. SC 14D9/A SC 14D-9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Clas |
|
| June 18, 2018 |
DSKX / DS Healthcare Group, Inc. SC 14D9/A SC 14D-9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Clas |
|
| June 12, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 6) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer |
|
| June 12, 2018 |
Press Release issued by Medilogistics Corp., issued on June 12, 2018. Press Release EXHIBIT (a)(1)(ix) MEDILOGISTICS CORP. ANNOUNCES EXTENSION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., June 12, 2018 — Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidders”), in c |
|
| June 6, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 5) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go |
|
| June 6, 2018 |
Press Release issued by Medilogistics Corp., issued on June 6, 2018. Press Release EXHIBIT (a)(1)(viii) MEDILOGISTICS CORP. ANNOUNCES EXTENSION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., June 6, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidders”), in c |
|
| June 1, 2018 |
DSKX / DS Healthcare Group, Inc. SC 14D9/A SC 14D9/A 1 dskx14d9.htm SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 |
|
| May 30, 2018 |
DSKX / DS Healthcare Group, Inc. SC 14D9 SC 14D9 1 dskx14d9.htm SC 14D9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Cla |
|
| May 30, 2018 |
Exhibit B (Forms 8K filed by the Board in support of its Rejection of the Offer) EXHIBIT B EXHIBIT B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 30, 2018 |
Exhibit A (Amended Offer and Transmittal Letter) Exhibit A EXHIBIT A OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| May 29, 2018 |
Press Release issued by Medilogistics Corp., issued on May 29, 2018. Press Release Exhibit (a)(1)(vii) MEDILOGISTICS CORP. ANNOUNCES NEW MINIMUM CONDITION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., May 29, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidd |
|
| May 29, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 4) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer |
|
| May 21, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 10, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| May 21, 2018 |
Offer to Purchase, dated May 21, 2018. OFFER TO PURCHASE EXHIBIT (a)(1)(i) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| May 21, 2018 |
Form of Contingent Value Rights Agreement. Exhibit (d)(1)(v) FORM OF CONTINGENT VALUE RIGHTS AGREEMENT Table of Contents ARTICLE I FORM OF CONTINGENT VALUE RIGHTS AGREEMENT 1 ARTICLE I DEFINITIONS; INTERPRETATION 1 Section 1. |
|
| May 21, 2018 |
Press Release issued by Medilogistics Corp., issued on May 21, 2018. Press Release Exhibit (a)(1)(vi) MEDILOGISTICS CORP. ANNOUNCES EXTENSION OF TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., May 21, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidders”), in connect |
|
| May 21, 2018 |
EX-99.(A)(1)(II) 3 gutierrezexa1ii.htm LETTER OF TRANSMITTAL Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. AT $0.07 NET PER SHARE, PLUS ONE CONTINGENT VALUE RIGHT PER SHARE REPRESENTING THE RIGHT TO AN AMOUNT EQUAL TO 80% OF ANY POTENTIAL PROCEEDS FROM A PENDING LAWSUIT BY MEDILOGISTICS CORP., A WHOLLY-OWNED SUBSIDIARY OF MEDILOGISTICS LLC T |
|
| May 21, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 3) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer |
|
| May 21, 2018 |
Form of Notice of Guaranteed Delivery. EX-99.(A)(1)(III) 4 gutierrezexa1iii.htm NOTICE OF GUARANTEED DELIVERY Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY FOR TENDER OF SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. AT $0.07 NET PER SHARE, PLUS ONE CONTINGENT VALUE RIGHT PER SHARE REPRESENTING THE RIGHT TO AN AMOUNT EQUAL TO 80% OF ANY POTENTIAL PROCEEDS FROM A PENDING LAWSUIT PURSUANT TO THE OFFER TO PURCHASE, AS AMENDED AND |
|
| May 16, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go |
|
| May 10, 2018 |
Offer to Purchase, dated May 9, 2018. OFFER TO PURCHASE EXHIBIT (a)(1)(i) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| May 10, 2018 |
Form of Notice of Guaranteed Delivery. NOTICE OF GUARANTEED DELIVERY Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY FOR TENDER OF SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| May 10, 2018 |
LETTER OF TRANSMITTAL Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| May 10, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go |
|
| May 7, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| May 7, 2018 |
DSKX / DS Healthcare Group, Inc. CURRENT REPORT (Prospectus) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| April 30, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T SC TO-T SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Gomez Mont (Names of F |
|
| April 30, 2018 |
Offer to Purchase, dated April 30, 2018. OFFER TO PURCHASE EXHIBIT (a)(1)(i) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| April 30, 2018 |
CONTRIBUTION AGREEMENT EXHIBIT (d)(1)(iv) CONTRIBUTION AGREEMENT among MEDILOGISTICS LLC and FERNANDO TAMEZ GUTIERREZ dated April 21, 2018 TABLE OF CONTENTS Article I. |
|
| April 30, 2018 |
Press Release issued by Medilogistics Corp., issued on April 30, 2018. Press Release Exhibit (a)(1)(v) MEDILOGISTICS CORP. ANNOUNCES COMMENCEMENT OF TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., April 30, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont, announced today that it has comm |
|
| April 30, 2018 |
EX-99.(A)(1)(II) 3 gutierrezexa1ii.htm FORM OF LETTER OF TRANSMITTAL Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. AT $0.07 NET PER SHARE BY MEDILOGISTICS CORP., A WHOLLY-OWNED SUBSIDIARY OF MEDILOGISTICS LLC THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON MAY 29, 2018, UNLESS THE OFFER IS EXTENDED (SUCH DATE |
|
| April 30, 2018 |
Summary Advertisement as published on April 30, 2018. Summary Advertisement Exhibit (a)(1)(iv) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). |
|
| April 30, 2018 |
Form of Notice of Guaranteed Delivery. NOTICE OF GUARANTEED DELIVERY Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY FOR TENDER OF SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. |
|
| April 26, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 10, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| April 26, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 5, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio |
|
| April 25, 2018 |
DSKX / DS Healthcare Group, Inc. SC TO-C SC TO-C 1 gutierrezsctoc.htm SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) Fernando Tamez Gutierrez Miguel Gomez Mont Medilogistics Corp. a wholly-owned subsidiary of |
|
| April 24, 2018 |
Amendment No. 3 to Schedule 13D filed by Fernando Tamez Gutierrez on April 24, 2018 SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1451 Brickell Avenue Unit 2701 Miami, FL 33131 (786) 856-8377 (Name, Address and |
|
| April 5, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC 13D/A Activist Investment SC 13D/A 1 gutierrez13d.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1451 Brickell Avenue Unit 2701 Miami, FL 33131 (786) |
|
| April 3, 2018 |
DSKX / DS Healthcare Group, Inc. NOTIFICATION OF LATE FILING Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): þ Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: DECEMBER 31, 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transit |
|
| February 1, 2018 |
Addendum to the Stock Purchase and Joint Venture Agreement EXHIBIT 1 August 11, 2017 ADDENDUM TO THE STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, And EverCare Prohealth Technologies LTD. |
|
| February 1, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC 13D/A Activist Investment SC 13D/A 1 gutierrez13d.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1040 Biscayne Blvd., Unit 1501 Miami, FL 33132 (786) |
|
| January 9, 2018 |
DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1040 Biscayne Blvd., Unit 1501 Miami, FL 33132 (786) 856-8377 (Name, Address and Telephone Numb |
|
| January 9, 2018 |
Addendum to the Stock Purchase and Joint Venture Agreement EX-3 2 gutierrezex3.htm ADDENDUM TO THE STOCK PURCHASE AND JOINT VENTURE AGREEMENT EXHIBIT 3 August 11, 2017 ADDENDUM TO THE STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, And EverCare Prohealth Technologies LTD. Dated: February 7, 2017 1 PURPOSE The purpose of this Addendum is to define the decentralization of operations and improve the distribution of DS Labora |
|
| December 8, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 16, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpor |
|
| November 14, 2017 |
DSKX / DS Healthcare Group, Inc. NOTIFICATION OF LATE FILING Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: SEPTEMBER 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transi |
|
| October 23, 2017 |
8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 18, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdic |
|
| October 13, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 13, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpora |
|
| October 13, 2017 |
Notice of Proposed Settlement of Derivitive Class Action EXHIBIT 99.1 IN THE CIRCUIT COURT OF THE 17TH JUDICIAL CIRCUIT IN AND FOR BROWARD COUNTY, FLORIDA CIVIL TRIAL DIVISION HANUL KIM, SAUL JAKUBOWITZ, YAFFA FITTERMAN, JAN SISSENER and ANNE-LOUISE SISSENER, Derivatively On Behalf of DS HEALTHCARE GROUP, INC., Plaintiffs, CASE NO. CACE-17-009773 v. DANIEL KHESIN, RENEE BARCH-NILES, MARK BROCKELMA |
|
| October 2, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 30, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organ |
|
| September 6, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): Septmber 1, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpora |
|
| September 6, 2017 |
DS Healthcare Updates Shareholders on State of the Business and an Operational Restructuring Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on State of the Business and an Operational Restructuring POMPANO BEACH, FL / ACCESSWIRE / September 5, 2017 / DS Healthcare Group, Inc. (DSKX) ("DSH? or the "Company") announced today that effective September 1, 2017, we finalized a restructuring of the Joint Venture Agreement with Evercare ProHealth Technologies Ltd. (?ECPT?). Over th |
|
| August 15, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 14, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| August 14, 2017 |
EX-10.1 2 dskxex10z1.htm EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“ Agreement ”) is made and entered into June 30, 2017(the “Execution Date” ), by and between DS HEALTHCARE GROUP, INC. a Florida corporation (collectively, the “ Company ”), and FERNANDO TAMEZ (“ Executive ”). RECITALS WHEREAS, the Company is presently engaged in developing products for skin |
|
| August 14, 2017 |
DSKX / DS Healthcare Group, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2017 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP |
|
| August 1, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio |
|
| July 18, 2017 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 17, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio |
|
| June 27, 2017 |
DS Healthcare Updates Shareholders on Settlement of Photomedex Lawsuit Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on Settlement of Photomedex Lawsuit POMPANO BEACH, FL / ACCESSWIRE / June 26, 2017 / DS Healthcare Group (DSKX) today announced that it has reached an agreement, effective June 23, 2017, to settle the lawsuit, pending in the United States Federal Court in New York. The suit has been dismissed by the court. The lawsuit had alleged a brea |
|
| June 27, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 23, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio |
|
| June 5, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 1, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| June 5, 2017 |
Employment Agreement EXHIBIT 99.3 |
|
| June 5, 2017 |
Employment Agreement EXHIBIT 99.2 |
|
| June 5, 2017 |
DS Healthcare Updates Shareholders on Corporate Changes Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on Corporate Changes POMPANO BEACH, FL / ACCESSWIRE / June 05, 2017 / DS Healthcare Group (DSKX) today announced that Yasuhiro Fujiwara, formerly the Chairman of the Board, has been selected as DS Healthcares new Chief Executive Officer. Mr. Fujiwara will assume the new role effective immediately and will replace Daniel Khesin, who wil |
|
| June 5, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 2, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| June 5, 2017 |
DS Healthcare Updates Shareholders on Settlement of Class Action Lawsuit Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on Settlement of Class Action Lawsuit POMPANO BEACH, FL / ACCESSWIRE / June 05, 2017 / DS Healthcare Group (DSKX) today announced that it has reached an agreement, effective June 02, 2017, to settle the securities class action and the plaintiffs derivative lawsuits, pending in the United States District Court for the Southern District |
|
| May 18, 2017 |
DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 16, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| May 15, 2017 |
DS Healthcare Group QUARTERLY REPORT (Quarterly Report) Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2017 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROU |
|
| May 15, 2017 |
STOCK PURCHASE AND JOINT VENTURE AGREEMENT EXHIBIT 10.1 STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, And EverCare Prohealth Technologies LTD. Dated: February 7, 2017 STOCK PURCHASE AND JOINT VENTURE AGREEMENT STOCK PURCHASE AND JOINT VENTURE AGREEMENT, dated and effective as of January 31, 2017 (this Agreement), by and among DS Healthcare Group, Inc., a Flori |
|
| March 31, 2017 |
DS Healthcare Group ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ??????? DS Healthcare Group |
|
| February 14, 2017 |
DS Healthcare Group SC 13G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 d327013dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Rule 13d-102) Amendment No. 2 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) DS Healthcare Group, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 23336Q109 (C |
|
| December 29, 2016 |
Financial Statements and Exhibits, Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 21, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpor |
|
| December 29, 2016 |
DS Healthcare Trading Halt Update EXHIBIT 99.1 DS Healthcare Trading Halt Update POMPANO BEACH, Fla., December 29, 2016 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (DSKX) (DS Healthcare or the Company") announce today that on December 21, 2016, DS Healthcare received notice from the Nasdaq Stock Market that its appeal of the delisting notification received on September 16, 2016 was rejected. After careful consideration, the Co |
|
| December 21, 2016 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 21, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpor |
|
| November 9, 2016 |
DS Healthcare Group QUARTERLY REPORT (Quarterly Report) Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2016 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE |
|
| October 18, 2016 |
DS Healthcare Group AMENDED QUARTERLY REPORT (Quarterly Report) Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS H |
|
| October 18, 2016 |
DS Healthcare Group AMENDED QUARTERLY REPORT (Quarterly Report) Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTH |
|
| October 14, 2016 |
DS Healthcare Group QUARTERLY REPORT (Quarterly Report) Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALT |
|
| October 7, 2016 |
DS Healthcare Group FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2016 (Quarterly Report) U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (mark one) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2016 ? Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact nam |
|
| October 7, 2016 |
DS Healthcare Group FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 (Quarterly Report) 10-Q 1 dskx19010q.htm FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (mark one) ☑ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2016 ☐ Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to |
|
| October 7, 2016 |
DS Healthcare Group ANNUAL REPORT (Annual Report) 10-K 1 dskx10k.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ——————— |
|
| October 7, 2016 |
DS Healthcare Group (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 28, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction (Commission File (I.R.S. E |
|
| September 23, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 16, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpo |
|
| September 23, 2016 |
DS Receives Staff Determination Letter From NASDAQ Press Release EXHIBIT 99.1 DS Receives Staff Determination Letter From NASDAQ September 21, 2016 Company Will Appeal Denial of 180 Day Extension Period POMPANO BEACH, FL / ACCESSWIRE / September 21, 2016 / On September 16th, 2016, DS Healthcare Group (DSKX) received a letter from the NASDAQ Market informing the company of its decision to delist the Company's securities due to perceived violations |
|
| September 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 12, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organ |
|
| August 26, 2016 |
Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| August 26, 2016 |
Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| August 24, 2016 |
Auditor Letter EXHIBIT 16.1 August 18, 2016 U.S. Securities and Exchange Commission 100 Fifth Street, N.E. Washington, DC 20549 We have read the statements made by DS Healthcare Group, Inc. (?the Company?) under Item 4.01 of its Form 8-K dated August 16, 2016. We agree with the statements concerning our Firm in such Form 8-K, except that we would add that during the course of our audit, we determi |
|
| August 24, 2016 |
DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| August 24, 2016 |
DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| August 24, 2016 |
Auditor Letter EXHIBIT 16.1 August 18, 2016 U.S. Securities and Exchange Commission 100 Fifth Street, N.E. Washington, DC 20549 We have read the statements made by DS Healthcare Group, Inc. (?the Company?) under Item 4.01 of its Form 8-K dated August 16, 2016. We agree with the statements concerning our Firm in such Form 8-K, except that we would add that during the course of our audit, we determi |
|
| August 16, 2016 |
Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| July 5, 2016 |
DSKX / DS Healthcare Group, Inc. / Khesin Daniel - SC 13D AMENDMENT NO. 1 Activist Investment SC 13D/A 1 khesinsc13d.htm SC 13D AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 13D ——————— Under the Securities Exchange Act of 1934 (Amendment No. 1)* DS Healthcare Group, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 23336Q109 (CUSIP Number) Daniel Khesin, 17689 Middlebrook Way, Boca Raton, FL 33496 – (347) 276-259 ( |
|
| July 5, 2016 |
Termination Notice EXHIBIT A From the desk of: Rose Schindler, Esq. One Boca Place, Suite 400-E 2255 Glades Road Boca Raton, Florida 33431 Phone: 561.994.2212 Fax: 561.997.8494 Email: [email protected] June 28, 2016 Re: Termination of Voting Agreement Dear Shareholders: Daniel is providing the following notification to all shareholders who granted him voting authority over their shares of D |
|
| June 1, 2016 |
DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| May 6, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation |
|
| May 6, 2016 |
Letter EXHIBIT 16.1 May 6, 2016 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by DS Healthcare Group, Inc. under Item 4.01 of its Form 8-K dated May 2, 2016. We agree with the statements concerning our Firm in such Form 8-K. We are not in a position to agree or disagree with other statements of DS Healthcare Group, Inc. c |
|
| May 6, 2016 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organization |
|
| April 26, 2016 |
DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 20, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| April 22, 2016 |
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CASE NO. 16-60661-CIV-DIMITROULEAS ORDER GRANTING MOTION TO TERMINATE EXHIBIT 1 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CASE NO. |
|
| April 22, 2016 |
DS Healthcare Group INFORMATION STATEMENT SC 14F1 1 dskx14f1.htm INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14f-1 INFORMATION STATEMENT PURSUANT TO SECTION 14f OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER DS Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Florida 333-195344 20-8380461 (State or other jurisdiction of (Commission Fi |
|
| April 15, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 14, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| April 14, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 14, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| April 6, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 31, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| April 4, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 2, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio |
|
| April 4, 2016 |
DS Healthcare Calls For Federal Government to Take Action to Protect Shareholders Press Release Exhibit 99.1 Press Release DS Healthcare Calls For Federal Government to Take Action to Protect Shareholders Published: Apr 3, 2016 9:30 p.m. ET Terminated President Violated Federal Securities Laws and Unlawfully Seized Control of the Company; Chief Financial Officer Steps Down POMPANO BEACH, Fla., Apr 03, 2016 (BUSINESS WIRE) - The board and management of DS Healthcare Group (?DS H |
|
| April 4, 2016 |
DS Healthcare Group DEFINITIVE PROXY STATEMENT Schedule 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant Filed by Party other than Registrant ? Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2) |
|
| March 31, 2016 |
DSKX / DS Healthcare Group, Inc. / Khesin Daniel - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 13D ——————— Under the Securities Exchange Act of 1934 (Amendment No. )* DS Healthcare Group, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 23336Q109 (CUSIP Number) Daniel Khesin, 17689 Middlebrook Way, Boca Raton, FL 33496 – (347) 276-259 (Name, Address and Telephone Number of Person |
|
| March 31, 2016 |
EX-99.B 3 sc13dexhibitb.htm AGREEMENTS OF SHAREHOLDERS TO TRANSFER VOTING AUTHORITY EXHIBIT B |
|
| March 31, 2016 |
List of Transactions EXHIBIT A Person Reporting Date of Transaction Title of Class Number of Shares Daniel Khesin March 29, 2016 Common Shares 1,075,000 Daniel Khesin March 29, 2016 Common Shares 10,455 Daniel Khesin March 29, 2016 Common Shares 1,274,000 Daniel Khesin March 29, 2016 Common Shares 100,000 Daniel Khesin March 29, 2016 Common Shares 200,000 Daniel Khesin March 29, 2016 Common Shares 271. |
|
| March 30, 2016 |
DS Healthcare Group NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 28, 2016 |
DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 28, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| March 28, 2016 |
DS HEALTHCARE GROUP COMMENTS ON RECENT DEVELOPMENTS EX-99.1 2 dskxex99z1.htm PRESS RELEASE Exhibit 99.1 DS HEALTHCARE GROUP COMMENTS ON RECENT DEVELOPMENTS POMPANO BEACH, Fla., March 28, 2016 (GLOBE NEWSWIRE) – On March 23, 2016, DS Healthcare Group, Inc., a Florida corporation (the “Company”) (NASDAQ:DSKX) filed a Current Report on Form 8-K with the SEC disclosing that the audit committee of the Board of Directors (the “Board”) concluded that the |
|
| March 23, 2016 |
1601 Green Road Pompano Beach, Florida 33064 EX-99.1 2 dskxex99z1.htm LETTER 1601 Green Road Pompano Beach, Florida 33064 March 17, 2016 Daniel Khesin 17689 Middlebrook Way Boca Raton, FL 33496 Dear Mr. Khesin, Pursuant to Section 4.1(a)(i) of your Employment Agreement dated December 16, 2013, the board of directors of DS HealthCare Group, Inc. (the “Company”) are hereby terminating your employment as an executive officer and employee of the |
|
| March 23, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 17, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati |
|
| March 23, 2016 |
SEC EDGAR FILING |
|
| February 25, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Inc |
|
| February 25, 2016 |
Form of Articles of Amendment to the Articles of Incorporation Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter |
|
| February 25, 2016 |
EX-10.3 2 dskxex10z3.htm CORRECTED FORM OF ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Busine |
|
| February 25, 2016 |
DS Healthcare Group AMENDED CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Juri |
|
| February 22, 2016 |
EX-10.4 5 dskxex10z4.htm FORM OF STOCKHOLDERS AGREEMENT Exhibit 10.4 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. RADIANCY, INC. PHOTOMEDEX TECHNOLOGIES, INC. and PHOTOMEDEX, INC. Dated: , 2016 { STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 2016 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc., |
|
| February 22, 2016 |
EX-10.5 6 dskxex10z5.htm FORM OF TRANSITION SERVICES AGREEMENT Exhibit 10.5 TRANSITION SERVICES AGREEMENT This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated , 2016 and to be effective as of the 1st day of 2016 (the “Effective Date”), is made and entered into by and between DS Healthcare Group, Inc., a Florida corporation (“DSKX”) and Photomedex, Inc., a Nevada corporation (“PHMD”). RECIT |
|
| February 22, 2016 |
EX-10.2 3 dskxex10z2.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD CONSUMER ACQUISITION CORP. RADIANCY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made as of Februa |
|
| February 22, 2016 |
DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Business Exhibit 99.1 DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Businesses COMBINATION CREATES A GLOBAL LEADER OF DISRUPTIVE TECHNOLOGIES WITH INDUSTRY’S MOST DIVERSIFIED PRODUCT PORTFOLIO. TRANSACTION WILL GENERATE OVER $60 MILLION IN ADDITIONAL GROSS SALES WITHIN THE FIRST 12 MONTHS. POMPANO BEACH, Fla., February 22, 2016 (GLOBE NEWSWIRE) - DS Healthcare Group, |
|
| February 22, 2016 |
FORM OF REGISTRATION RIGHTS AGREEMENT Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of , 2016, among DS Healthcare Group, Inc., a Florida corporation (the “Company”) and Photomedex, Inc., a Nevada corporation (“PHMD”) and any subsequent PHMD Transferee (together with PHMD, individually and collectively, the “S |
|
| February 22, 2016 |
Form of Articles of Amendment to the Articles of Incorporation Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter |
|
| February 22, 2016 |
DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Business EX-99.1 8 dskxex99z1.htm PRESS RELEASE Exhibit 99.1 DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Businesses COMBINATION CREATES A GLOBAL LEADER OF DISRUPTIVE TECHNOLOGIES WITH INDUSTRY’S MOST DIVERSIFIED PRODUCT PORTFOLIO. TRANSACTION WILL GENERATE OVER $60 MILLION IN ADDITIONAL GROSS SALES WITHIN THE FIRST 12 MONTHS. POMPANO BEACH, Fla., February 22, 2016 ( |
|
| February 22, 2016 |
EX-10.1 2 dskxex10z1.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD PROFESSIONAL ACQUISITION CORP. PHOTOMEDEX TECHNOLOGY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS 1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) i |
|
| February 22, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Juri |
|
| February 22, 2016 |
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD CONSUMER ACQUISITION CORP. RADIANCY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made as of February 19, 2016, (the “Execut |
|
| February 22, 2016 |
EX-10.4 5 dskxex10z4.htm FORM OF STOCKHOLDERS AGREEMENT Exhibit 10.4 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. RADIANCY, INC. PHOTOMEDEX TECHNOLOGIES, INC. and PHOTOMEDEX, INC. Dated: , 2016 { STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 2016 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc., |
|
| February 22, 2016 |
FORM OF TRANSITION SERVICES AGREEMENT Exhibit 10.5 TRANSITION SERVICES AGREEMENT This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated , 2016 and to be effective as of the 1st day of 2016 (the “Effective Date”), is made and entered into by and between DS Healthcare Group, Inc., a Florida corporation (“DSKX”) and Photomedex, Inc., a Nevada corporation (“PHMD”). RECITALS: WHEREAS, pursuant to |
|
| February 22, 2016 |
EX-10.3 4 dskxex10z3.htm FORM OF ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Business Cor |
|
| February 22, 2016 |
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD PROFESSIONAL ACQUISITION CORP. PHOTOMEDEX TECHNOLOGY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS 1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made as of February 19, |
|
| February 22, 2016 |
DEFA14A 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jur |
|
| February 22, 2016 |
FORM OF REGISTRATION RIGHTS AGREEMENT Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of , 2016, among DS Healthcare Group, Inc., a Florida corporation (the “Company”) and Photomedex, Inc., a Nevada corporation (“PHMD”) and any subsequent PHMD Transferee (together with PHMD, individually and collectively, the “S |
|
| February 22, 2016 |
DS Healthcare Group AMENDED CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Juri |
|
| February 22, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organi |
|
| February 18, 2016 |
Submission of Matters to a Vote of Security Holders Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 11, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorpor |
|
| February 5, 2016 |
DSKX / DS Healthcare Group, Inc. / Frigate Ventures LP - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Rule 13d-102) Amendment No. |
|
| January 11, 2016 |
8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 5, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdict |
|
| January 11, 2016 |
Employment Letter EXHIBIT 10.1 January 5th, 2016 Dear Mark, It is my pleasure to extend the following offer of full-time employment to you on behalf of DS Healthcare Group, Inc. This offer is contingent upon your satisfactory completion of a pre-employment confidentiality agreement, standard background check and our receipt of your identity/employment eligibility. Title: CFO Reporting Relationship |
|
| January 11, 2016 |
Miami Dolphins CFO joins DS Healthcare EX-99.1 3 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 Miami Dolphins CFO joins DS Healthcare Pompano Beach, Fla., January 6, 2016 (GLOBE NEWSWIRE) - Mark Brockelman has joined DS Healthcare Group to help scale its innovative organization into a market leading health and wellness powerhouse focused on technologically advanced, consumer-driven personal care solutions. He will oversee all aspects of th |
|
| January 8, 2016 |
DS Healthcare Group REVISED PROXY STATEMENT Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Under ? 240. |
|
| January 5, 2016 |
DSKX / DS Healthcare Group, Inc. / Del Mar Asset Management, LP - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1) Under the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 23336Q109 (CUSIP Number) December 24, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| January 5, 2016 |
EX-99.1 2 d113175dex991.htm EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.001 par value, of DS Healthcare Group, Inc., a Florida corpor |
|
| January 5, 2016 |
DSKX / DS Healthcare Group, Inc. / Frigate Ventures LP - SC 13G Passive Investment SC 13G 1 d113175dsc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) DS Healthcare Group Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 23336Q109 (CUSIP Number) December 17 |
|
| December 31, 2015 |
DS Healthcare Group PROXY STATEMENT Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Under ? 240. |
|
| December 30, 2015 |
EXECUTIVE EMPLOYMENT AGREEMENT EXHIBIT 10.4 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the ?Agreement?) is entered into this day of 2016 (the ?Effective Date?), by and among DS HEALTHCARE GROUP, INC., a Florida corporation (?DSH?); W/R GROUP, INC. (formerly, WRG Acquisition Corporation), a corporation organized under the laws of the laws of the State of Arizona, (the ?Company?); and CAREY WILLIAMS, an i |
|
| December 30, 2015 |
[Remainder of page intentionally left blank.] EX-10.5 6 dskxex10z5.htm FINANCING LETTER CONFIDENTIAL - NOT A COMMITMENT EXHIBIT 10.5 December 28, 2015 DS Healthcare Group, Inc. 1601 Green Road Pompano Beach, FL 33064 Ladies and Gentlemen: You have advised White Oak Global Advisors, LLC (“White Oak” or "we") that DS Healthcare Group, Inc., a Florida corporation (“DSH” or “you”) has entered into an Amended and Restated Asset Purchase Agreement |
|
| December 30, 2015 |
EX-10.3 4 dskxex10z3.htm FORM OF STOCKHOLDERS AGREEMENT EXHIBIT 10.3 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. CAREY WILLIAMS and STEFAN RUSSELL Dated: , 201 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 201 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc., a Florida corporation (“DSH” or the |
|
| December 30, 2015 |
Amended and Restated Merger Agreement EXHIBIT 10.2 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. AND STEFAN RUSSELL, As of DECEMBER 23, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 The Closing 2 1.3 Actions at the Closing 2 1.4 Additional Actions 3 1.5 Conversion of Company Comm |
|
| December 30, 2015 |
EX-10.1 2 dskxex10z1.htm AMENDED AND RESTATED ASSET PURCHASE AGREEMENT EXHIBIT 10.1 AMENDED AND RESTATED ASSET PURCHASE AGREEMENT AMONG DS HEALTHCARE GROUP, INC., WRG ACQUISITION CORPORATION W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, AND CAREY WILLIAMS As of DECEMBER 23, 2015 TABLE OF CONTENTS BACKGROUND 1 ARTICLE I – SALE AND PURCHASE OF ASSETS 2 Section 1.1 Purchased Assets 2 Secti |
|
| December 30, 2015 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 23, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorpor |
|
| December 29, 2015 |
DS Healthcare Group AMENDED CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment Number 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other j |
|
| December 22, 2015 |
2,000,000 Shares of Common Stock DS HEALTHCARE GROUP, INC. Prospectus Supplement Filed Pursuant to Rule 424(b)(5) Registration No. 333-195344 PROSPECTUS SUPPLEMENT (To the Prospectus Dated July 25, 2014) 2,000,000 Shares of Common Stock DS HEALTHCARE GROUP, INC. We are offering 2,000,000 shares of our common stock, $0.001 par value per share, to selected investors pursuant to this prospectus supplement and the accompanying prospectus and a securities purc |
|
| December 21, 2015 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this Agreement) is dated as of December 17, 2015, between DS Healthcare Group, Inc., a Florida corporation (the Company), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a Purchaser and collectively the Purchasers). WHEREAS, subject to the terms and condit |
|
| December 21, 2015 |
Form of Warrant EXHIBIT 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN E |
|
| December 21, 2015 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpor |
|
| December 21, 2015 |
DS Healthcare Announces $5 Million Registered Direct Offering to Finalize Senior Debt Requirements EX-99.1 6 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 DS Healthcare Announces $5 Million Registered Direct Offering to Finalize Senior Debt Requirements Pompano Beach Fla., Dec. 18, 2015 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (Nasdaq:DSKX) (the "Company" or "DSKX") announced that it entered into a definitive securities purchase agreement with certain institutional investors for the issuance of |
|
| December 21, 2015 |
Engagement Letter with Placement Agent EXHIBIT 10.2 December 16, 2015 STRICTLY CONFIDENTIAL Abner Silva Chief Operating Officer DS Healthcare Group, Inc. 1601 Green Road Pompano Beach FL 33064 Dear Mr. Silva: This letter agreement (this Agreement) constitutes the agreement between DS Healthcare Group, Inc. (the Company) and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (Rodman), a b |
|
| December 21, 2015 |
EXHIBIT 10.3 December 18, 2015 STRICTLY CONFIDENTIAL DS Healthcare Group, Inc. 1601 Green Road Pompano Beach FL 33064 Attn: Abner Silva Dear Mr. Silva Reference is made to the engagement letter (the Engagement Letter), dated December 16, 2015 by and between DS Healthcare Group, Inc. (the Company) and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (Rodman),. Defined terms used herein |
|
| November 16, 2015 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exac |
|
| October 27, 2015 |
EX-10.1 2 dskxex10z1.htm EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into by and between DS HEALTHCARE GROUP, INC., (NASDAQ: DSKX) (a.k.a. DS Laboratories) Headquartered in Pompano Beach, Florida, a Florida corporation (the “Company”), and RENEE BARCH-NILES (the “Executive”), on this 26th day of October, 2015. RECITALS WHER |
|
| October 27, 2015 |
DS Healthcare Names Renee Barch-Niles Chief Executive Officer Press Release EXHIBIT 99.1 DS Healthcare Names Renee Barch-Niles Chief Executive Officer Pompano Beach, Fla., Oct. 26, 2015 - DS Healthcare Group, Inc. (DSKX) today announced that Renee Barch-Niles has been named Chief Executive Officer. Barch-Niles succeeds Daniel Khesin, DS Healthcare?s founding CEO. Khesin will continue to serve as Chairman and will lead product innovation. Renee Barch-Niles ha |
|
| October 27, 2015 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpora |
|
| October 16, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpora |
|
| October 16, 2015 |
Company executes term sheet for $35 million debt facility Press Release Exhibit 99.1 DS HEALTHCARE PROVIDES UPDATE ON WR GROUP ACQUISITION. Company executes term sheet for $35 million debt facility Pompano Beach, Fla., October 16, 2015 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (NASDAQ:DSKX) (?DS Healthcare? or the "Company") announced here today that it has executed a term sheet with a middle market lender which will provide the Company with $35 milli |
|
| September 29, 2015 |
Form of Stockholders Agreement EXHIBIT 10.3 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. CAREY WILLIAMS and STEFAN RUSSELL Dated: , 2015 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this Agreement), to be effective as of [*], 2015 (the Effective Date) is made and entered into by and among (A) DS Healthcare Group, Inc., a Florida corporation (DSH or the Corporation); (B) St |
|
| September 29, 2015 |
EX-10.2 3 dskxex10z2.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. AND STEFAN RUSSELL, As of AUGUST 31, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 The Closing 2 1.3 Actions at the Closing 2 1.4 Additional Actions 3 1.5 Conversion of |
|
| September 29, 2015 |
EX-10.1 2 dskxex10z1.htm ASSET PURCHASE AGREEMENT EXHIBIT 10.1 ASSET PURCHASE AGREEMENT AMONG DS HEALTHCARE GROUP, INC., WRG ACQUISITION CORPORATION W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, AND CAREY WILLIAMS As of AUGUST 31, 2015 TABLE OF CONTENTS BACKGROUND 1 ARTICLE I – SALE AND PURCHASE OF ASSETS 2 Section 1.1 Purchased Assets 2 Section 1.2 Excluded Assets 4 Section 1.3 Assumed |
|
| September 29, 2015 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 24, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorpo |
|
| August 17, 2015 |
DS HEALTHCARE ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE WR GROUP Press Release EXHIBIT 99.1 DS HEALTHCARE ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE WR GROUP Combined business expected to have approximately $65 million in annual revenues and $10 million in EBITDA from over 20 countries, 900 unique and diversified products, and a broad range of personal care categories. Resulting synergies provide a platform for rapid growth. Pompano Beach, Fla., August 17, 201 |
|
| August 17, 2015 |
Stock Purchase Agreement EXHIBIT 10.1 STOCK PURCHASE AGREEMENT AMONG DS HEALTHCARE, INC., W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, AND CAREY WILLIAMS As of JULY 31, 2015 TABLE OF CONTENTS Page ARTICLE I PURCHASE OF THE SUBJECT SHARES 1 1.1 Sale and Purchase 1 1.2 The Closing 7 1.3 Actions at the Closing 7 1.4 Additional Actions 8 1.12 Transfer Books; Bank Accounts 8 ARTICLE II REPR |
|
| August 17, 2015 |
EX-10.2 3 dskxex10z2.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. AND STEFAN RUSSELL, As of JULY 31, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 The Closing 2 1.3 Actions at the Closing 2 1.4 Additional Actions 3 1.5 Conversion of Co |
|
| August 17, 2015 |
EX-10.3 4 dskxex10z3.htm FORM OF STOCKHOLDERS AGREEMENT EXHIBIT 10.3 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. CAREY WILLIAMS and STEFAN RUSSELL Dated: , 2015 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 2015 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc., a Florida corporation (“DSH” or t |
|
| August 17, 2015 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorporat |
|
| August 14, 2015 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact nam |
|
| August 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commission |
|
| June 9, 2015 |
DS HEALTHCARE GROUP, INC. 1601 Green Road Pompano Beach, Florida 33064 June 9, 2015 Via EDGAR Securities and Exchange Commission 100 F Street, N.W. Washington, D.C. 20549 Attention: David Korvin Re: DS Healthcare Group, Inc. Registration Statement on Form S-3 Filed June 2, 2015 File No. 333-204651 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, DS Healthcar |
|
| June 2, 2015 |
EX-10.1 3 dskxex10z1.htm CONSULTING AGREEMENT EXHIBIT 10.1 CONSULTING AGREEMENT This Consulting Agreement (“Agreement”) is entered into effective as of , 2015 by and between DS Health Care Group, Inc. (the “Company”) and RP Innovative Consulting, LLC (“Consultant”). The Company desires to retain Consultant on a contract basis to perform consulting services for the Company, and Consultant is willin |
|
| June 2, 2015 |
DS Healthcare Group REGISTRATION STATEMENT S-3 1 dskxs3.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on June 2, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DS Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Florida 20-8380461 (State or other jurisdiction of |
|
| May 20, 2015 |
10-Q 1 dskx10q.htm QUARTERLY REPORT U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 |
|
| May 18, 2015 |
DS Healthcare Group NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 8, 2015 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) |
|
| May 1, 2015 |
DS Healthcare Group REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on May 1, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 30, 2015 |
8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdicti |
|
| April 16, 2015 |
Press Release EXHIBIT 99.1 DS Healthcare Group Reports Fourth Quarter and Full Year 2014 Financial Results as Company Reports Its First Profitable Quarter Revenue up 21% in Fourth Quarter From Same Period in 2013 POMPANO BEACH, Fla., April 15, 2015 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (DSKX), "DS Healthcare" or "the Company" a leading developer of personal care products has released financ |
|
| April 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commission |
|
| April 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ??????? DS Healthcare Group, Inc. (Exact |
|
| April 1, 2015 |
DS Healthcare Group NOTIFICATION OF LATE FILING NT 10-K 1 dskx12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ü Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2014 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on |
|
| January 14, 2015 |
Submission of Matters to a Vote of Security Holders Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpora |
|
| December 31, 2014 |
DSKX / DS Healthcare Group, Inc. DEF 14A - - PROXY STATEMENT DEF 14A 1 dskx14a.htm PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy Statement |
|
| December 19, 2014 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdi |
|
| November 14, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2014 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exac |
|
| August 15, 2014 |
EX-99.1 2 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 DS Healthcare Group Reports Second Quarter 2014 Financial Results Revenues, gross profits, and gross margins increase in Q2 2014 over prior year period Pompano Beach, Fla., August 15, 2014 – DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and six months ended |
|
| August 15, 2014 |
8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdict |
|
| August 14, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2014 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact nam |
|
| August 11, 2014 |
424B3 1 dskx424b.htm REGISTRATION STATEMENT Filed Pursuant to Rule 424(b)(3) Registration No. 333-195345 PROSPECTUS 1,965,000 shares This prospectus relates to periodic offers and sales of 1,965,000 shares of our common stock by the selling shareholders. These shares may be sold from time to time by the selling shareholder and their donees, pledgees, transferees or successors in interest. These sh |
|
| July 31, 2014 |
DSKX / DS Healthcare Group, Inc. CORRESP - - Acceleration Request DS HEALTHCARE GROUP, INC. 1601 Green Road Pompano Beach, Florida 33064 July 31, 2014 “CORRES” VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549-4631 Re: DS HEALTHCARE GROUP, INC. Registration Statement on Form S-3 File No. 333-195345 Ladies and Gentlemen: The under undersigned registrant hereby |
|
| July 31, 2014 |
DSKX / DS Healthcare Group, Inc. CORRESP - - Acceleration Request DS HEALTHCARE GROUP, INC. 1601 Green Road Pompano Beach, Florida 33064 July 31, 2014 “CORRES” VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549-4631 Re: DS HEALTHCARE GROUP, INC. Registration Statement on Form S-3 File No. 333-195344 Ladies and Gentlemen: The under undersigned registrant hereby |
|
| July 25, 2014 |
DSKX / DS Healthcare Group, Inc. S-3/A - - REGISTRATION STATEMENT Amended Registration Statement As filed with the Securities and Exchange Commission on July 25, 2014 Registration No. |
|
| July 15, 2014 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorporatio |
|
| July 3, 2014 |
DSKX / DS Healthcare Group, Inc. S-3/A - - REGISTRATION STATEMENT Amended Registration Statement As filed with the Securities and Exchange Commission on July 3, 2014 Registration No. |
|
| July 3, 2014 |
DSKX / DS Healthcare Group, Inc. S-3/A - - REGISTRATION STATEMENT Amended Registration Statement As filed with the Securities and Exchange Commission on July 3, 2014 Registration No. |
|
| July 3, 2014 |
DSKX / DS Healthcare Group, Inc. CORRESP - - Response Letter PEARLMAN SCHNEIDER LLP Attorneys-at-Law 2200 Corporate Boulevard, N. |
|
| July 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorporation) (Commission |
|
| May 15, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2014 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact na |
|
| April 17, 2014 |
Registration Statement As filed with the Securities and Exchange Commission on April 17, 2014 Registration No. |
|
| April 17, 2014 |
Registration Statement As filed with the Securities and Exchange Commission on April 17, 2014 Registration No. |
|
| April 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ??????? DS Healthcare Group, Inc. (Exact |
|
| April 1, 2014 |
Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 10, 2014 |
DSKX / DS Healthcare Group, Inc. / Phoenix Investment Fund Inc. - SC 13G/A Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 23336Q109 (CUSIP Number) December 31, 2013 (Date of Event which R |
|
| January 6, 2014 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorporat |
|
| January 6, 2014 |
Amendment Agreement EXHIBIT 10.2 AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT (this “Agreement”), dated as of December 30, 2013 is entered into by and between DS HEALTHCARE GROUP, INC., a Florida corporation (the “Company”) and DEL MAR MASTER FUND, LTD. (the “Holder”). Capitalized terms used herein, but not otherwise defined, shall have the meanings ascribed to such terms in the Purchase Agreement |
|
| January 6, 2014 |
DS Healthcare Group Completes Private Placement of $3,144,000 Dollars EX-99.1 3 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 DS Healthcare Group Completes Private Placement of $3,144,000 Dollars Pompano Beach, Jan. 06, 2013 (GLOBE NEWSWIRE) – DS Healthcare Group, Inc. (Nasdaq: DSKX), a developer of personal care products, today announced that it has completed its securities purchase agreement with a group of accredited investors for the sale of 1,965,000 shares of the |
|
| December 27, 2013 |
DSKX / DS Healthcare Group, Inc. / Del Mar Asset Management, LP - SC 13G Passive Investment SC 13G 1 delmar13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 23336Q109 (CUSIP Number) December 24, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| December 26, 2013 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 24, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorpor |
|
| December 26, 2013 |
DS Healthcare Group Announces Private Placement of $2,420,000 Million Dollars EX-99.1 3 dskxex99z1.htm PRRESS RELEASE EXHIBIT 99.1 DS Healthcare Group Announces Private Placement of $2,420,000 Million Dollars Pompano Beach, Fla., December 25, 2013 – DS Healthcare Group, Inc. (Nasdaq: DSKX), a developer of personal care products, today announced that it entered and consummated a securities purchase agreement with an accredited investor for the sale of 1,512,500 shares of the |
|
| December 26, 2013 |
SECURITIES PURCHASE AGREEMENT EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2013, between DS Healthcare Group, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, |
|
| December 17, 2013 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorpor |
|
| December 17, 2013 |
EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into December 16, 2013 (the “Execution Date”), by and between DS HEALTHCARE GROUP, INC. a Florida corporation (collectively, the “Company”), and DANIEL KHESIN (“Executive”). RECITALS WHEREAS, the Company is presently engaged in developing products for skin care and personal care needs |
|
| November 18, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorpor |
|
| November 14, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2013 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exac |
|
| November 1, 2013 |
- NOTICE OF PROPOSED SALE OF SECURITIES FORM 144 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0101 Washington, D. |
|
| October 31, 2013 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commissi |
|
| October 10, 2013 |
Auditor Letter EXHIBIT 16.1 October 4, 2013 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated October 4, 2013 of DS Healthcare Group, Inc. and are in agreement with the statements contained first sentence with regards to the dismissal of Cherry Bekaert LLP, the second and fourth sentence of the first para |
|
| October 10, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporat |
|
| October 10, 2013 |
Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| October 9, 2013 |
Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS EX-99.1 2 dskx99z1.htm FINANCIAL STATEMENTS EXHIBIT 99.1 Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS Unaudited Balance Sheets as of September 30, 2012 (as restated) and December 31, 2011 (as restated) F-2 Unaudited Statements of Operations for the nine months ended September 30, 2012 (as restated) and 2011 (as restated) F-3 Unaudited Statements of Changes in Shareholders’ E |
|
| October 9, 2013 |
Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 4 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdi |
|
| September 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commis |
|
| August 19, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2013 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-53680 DS HEALTHCARE GROUP, INC. (Exact nam |
|
| August 15, 2013 |
Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 25, 2013 |
Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS FINANCIAL STATEMENTS EXHIBIT 99.1 Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS Unaudited Balance Sheets as of September 30, 2012 and 2011 F-2 Unaudited Statements of Operations for the nine months ended September 30, 2012 and 2011 F-3 Unaudited Statements of Changes in Shareholders’ Equity for the nine months ended September 30, 2012 and 2011 F-4 Unaudited Statements of Cash |
|
| July 25, 2013 |
Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 3 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdi |
|
| July 25, 2013 |
EX-99.2 3 dskx99z2.htm PROFORMA FINANCIALS EXHIBIT 99.2 DS Healthcare Group, Inc. Pro-Forma Consolidated Balance Sheet September 30, 2012 DS Healthcare Group, Inc. (Consolidated) DS Laboratories, S.A. DE C.V. Acquisition Adjustment Acquisition Adjustment Elimination ProForma Consolidated Balance Sheet ASSETS Current Assets Cash $ 945,065 $ 70,762 $ 1,015,827 Accounts receivable, net 2,575,231 392, |
|
| July 19, 2013 |
- REGISTRATION WITHDRAWAL REQUEST Registration Withdrawal Request DS Healthcare Group, Inc. 1601 Green Road Pompano Beach, Florida 33064 July 19, 2013 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attn: Sherry Haywood Re: Form RW With Respect to Withdrawal of Registration Statement on Form S-1 (File No. 333-183558) Dear Ms. Haywood: Pursuant to Rule 477 pr |
|
| June 11, 2013 |
Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 2 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdi |
|
| June 11, 2013 |
Pro-Forma EXHIBIT 99.2 DS Healthcare Group, Inc. Pro-Forma Consolidated Balance Sheet September 30, 2012 DS Healthcare Group, Inc. (Consolidated) DS Laboratories, S.A. DE C.V. Acquisition Adjustment Acquisition Adjustment Elimination ProForma Consolidated Balance Sheet ASSETS Current Assets Cash $ 945,065 $ 70,762 $ 1,015,827 Accounts receivable, net 2,575,231 392,323 (255,676 ) (c) 2,711,878 Inve |
|
| June 11, 2013 |
Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS EX-99.1 2 dskx99z1.htm FINANCIAL STATEMENTS EXHIBIT 99.1 Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS Unaudited Balance Sheets as of September 30, 2012 and 2011 F-2 Unaudited Statements of Operations for the nine months ended September 30, 2012 and 2011 F-3 Unaudited Statements of Changes in Shareholders’ Equity for the nine months ended September 30, 2012 and 2011 F-4 Unaud |
|
| May 16, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2013 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-53680 DS HEALTHCARE GROUP, INC. (Exact na |
|
| May 16, 2013 |
Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 30, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2012 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-53680 DS HEALTHCARE GROUP, INC. (Na |
